| Bioactivity | Galidesivir (BCX4430; Immucillin-A) dihydrochloride is a broad-spectrum RNA virus inhibitor that can inhibit Ebola and yellow fever virus (Flavivirus) infections. Galidesivir has potent antiviral activity against tick-borne encephalitis virus (TBEV) and also inhibits the proliferation of many other medically important flaviviruses[1]. |
| Name | Galidesivir dihydrochloride |
| CAS | 1373208-51-5 |
| Formula | C11H17Cl2N5O3 |
| Molar Mass | 338.19 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Eyer L, et al. An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice. J Virol. 2019 Jul 30;93(16):e00367-19. |
Galidesivir dihydrochloride
CAS: 1373208-51-5 F: C11H17Cl2N5O3 W: 338.19
Galidesivir (BCX4430; Immucillin-A) dihydrochloride is a broad-spectrum RNA virus inhibitor that can inhibit Ebola and y
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.